192 related articles for article (PubMed ID: 19856104)
1. Inhibition of nuclear factor kappa B transcription activity drives a synergistic effect of pyrrolidine dithiocarbamate and cisplatin for treatment of renal cell carcinoma.
Morais C; Gobe G; Johnson DW; Healy H
Apoptosis; 2010 Apr; 15(4):412-25. PubMed ID: 19856104
[TBL] [Abstract][Full Text] [Related]
2. Pyrrolidine dithiocarbamate exerts anti-proliferative and pro-apoptotic effects in renal cell carcinoma cell lines.
Morais C; Pat B; Gobe G; Johnson DW; Healy H
Nephrol Dial Transplant; 2006 Dec; 21(12):3377-88. PubMed ID: 16998220
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of nuclear factor kappa B attenuates tumour progression in an animal model of renal cell carcinoma.
Morais C; Healy H; Johnson DW; Gobe G
Nephrol Dial Transplant; 2010 May; 25(5):1462-74. PubMed ID: 20037166
[TBL] [Abstract][Full Text] [Related]
4. Anti-angiogenic actions of pyrrolidine dithiocarbamate, a nuclear factor kappa B inhibitor.
Morais C; Gobe G; Johnson DW; Healy H
Angiogenesis; 2009; 12(4):365-79. PubMed ID: 19882112
[TBL] [Abstract][Full Text] [Related]
5. RRR-α-tocopheryl succinate induces apoptosis in human gastric cancer cells via the NF-κB signaling pathway.
Sun Y; Zhao Y; Hou L; Zhang X; Zhang Z; Wu K
Oncol Rep; 2014 Sep; 32(3):1243-8. PubMed ID: 24970592
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of pyrrolidine dithiocarbamate and cisplatin in human cervical carcinoma.
Zheng X; Lv J; Shen Q; Chen Y; Zhou Q; Zhang W; Zhu X
Reprod Sci; 2014 Oct; 21(10):1319-25. PubMed ID: 24594834
[TBL] [Abstract][Full Text] [Related]
7. The emerging role of nuclear factor kappa B in renal cell carcinoma.
Morais C; Gobe G; Johnson DW; Healy H
Int J Biochem Cell Biol; 2011 Nov; 43(11):1537-49. PubMed ID: 21854869
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of nuclear factor κB transcription activity drives a synergistic effect of cisplatin and oridonin on HepG2 human hepatocellular carcinoma cells.
Dong X; Liu F; Li M
Anticancer Drugs; 2016 Apr; 27(4):286-99. PubMed ID: 26704389
[TBL] [Abstract][Full Text] [Related]
9. [Reversal effect of nuclear factor-κB protease inhibitor PDTC on multidrug resistance of K562/AO₂ cells and its mechanism].
Yang TT; Xue TY; Xu W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):903-8. PubMed ID: 20723297
[TBL] [Abstract][Full Text] [Related]
10. Curcumin reverses chemoresistance of human gastric cancer cells by downregulating the NF-κB transcription factor.
Yu LL; Wu JG; Dai N; Yu HG; Si JM
Oncol Rep; 2011 Nov; 26(5):1197-203. PubMed ID: 21811763
[TBL] [Abstract][Full Text] [Related]
11. Role of Δ133p53 isoform in NF-κB inhibitor PDTC-mediated growth inhibition of MKN45 gastric cancer cells.
Zhang HM; Sang XG; Wang YZ; Cui C; Zhang L; Ji WS
World J Gastroenterol; 2017 Apr; 23(15):2716-2722. PubMed ID: 28487608
[TBL] [Abstract][Full Text] [Related]
12. Novel biphasic effect of pyrrolidine dithiocarbamate on neuronal cell viability is mediated by the differential regulation of intracellular zinc and copper ion levels, NF-kappaB, and MAP kinases.
Chung KC; Park JH; Kim CH; Lee HW; Sato N; Uchiyama Y; Ahn YS
J Neurosci Res; 2000 Jan; 59(1):117-25. PubMed ID: 10658192
[TBL] [Abstract][Full Text] [Related]
13. TNF-α-mediated NF-κB survival signaling impairment by cisplatin enhances JNK activation allowing synergistic apoptosis of renal proximal tubular cells.
Benedetti G; Fredriksson L; Herpers B; Meerman J; van de Water B; de Graauw M
Biochem Pharmacol; 2013 Jan; 85(2):274-86. PubMed ID: 23103562
[TBL] [Abstract][Full Text] [Related]
14. Pyrrolidine dithiocarbamate reverses Bcl-xL-mediated apoptotic resistance to doxorubicin by inducing paraptosis.
Park SS; Lee DM; Lim JH; Lee D; Park SJ; Kim HM; Sohn S; Yoon G; Eom YW; Jeong SY; Choi EK; Choi KS
Carcinogenesis; 2018 Mar; 39(3):458-470. PubMed ID: 29329420
[TBL] [Abstract][Full Text] [Related]
15. Chemoprotective effect of a nuclear factor-kappaB inhibitor, pyrrolidine dithiocarbamate, against cisplatin-induced testicular damage in rats.
Ilbey YO; Ozbek E; Simsek A; Cekmen M; Otunctemur A; Somay A
J Androl; 2009; 30(5):505-14. PubMed ID: 19234314
[TBL] [Abstract][Full Text] [Related]
16. p38-NF-κB-promoted mitochondria-associated apoptosis and G2/M cell cycle arrest in norcantharidin-treated HeLa cells.
Dong X; Li JC; Jiang YY; Xia MY; Tashiro S; Onodera S; Ikejima T
J Asian Nat Prod Res; 2012; 14(11):1008-19. PubMed ID: 23281704
[TBL] [Abstract][Full Text] [Related]
17. Amelioration of experimental autoimmune uveoretinitis (EAU) with an inhibitor of nuclear factor-kappaB (NF-kappaB), pyrrolidine dithiocarbamate.
Kitamei H; Iwabuchi K; Namba K; Yoshida K; Yanagawa Y; Kitaichi N; Kitamura M; Ohno S; Onoé K
J Leukoc Biol; 2006 Jun; 79(6):1193-201. PubMed ID: 16574770
[TBL] [Abstract][Full Text] [Related]
18. Involvement of activating transcription factors JNK, NF-kappaB, and AP-1 in apoptosis induced by pyrrolidine dithiocarbamate/Cu complex.
Chen SH; Lin JK; Liang YC; Pan MH; Liu SH; Lin-Shiau SY
Eur J Pharmacol; 2008 Oct; 594(1-3):9-17. PubMed ID: 18671963
[TBL] [Abstract][Full Text] [Related]
19. Involvement of NF-κB activation in the cisplatin resistance of human epidermoid carcinoma KCP-4 cells.
Oiso S; Ikeda R; Nakamura K; Takeda Y; Akiyama S; Kariyazono H
Oncol Rep; 2012 Jul; 28(1):27-32. PubMed ID: 22562377
[TBL] [Abstract][Full Text] [Related]
20. Suppression of experimental abdominal aortic aneurysms in mice by treatment with pyrrolidine dithiocarbamate, an antioxidant inhibitor of nuclear factor-kappaB.
Parodi FE; Mao D; Ennis TL; Bartoli MA; Thompson RW
J Vasc Surg; 2005 Mar; 41(3):479-89. PubMed ID: 15838484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]